Source: International Congress 2016 – Highlights in the management of COPD and beyond
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lies Lahousse (Ghent, Belgium), Lies Lahousse, Phebe De Nocker, Albert Hofman, Bruno Stricker, Guy Brusselle, Katia Verhamme. LSC Abstract – Potential use of β-blockers to reduce COPD exacerbations. Eur Respir J 2016; 48: Suppl. 60, 1502

Member's Comments

No comment yet.

Related content which might interest you: Modelling exacerbations of COPD Source: Annual Congress 2012 - Modelling respiratory infections: is it the future or the present? Year: 2012 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 COPD exacerbations: Causes and consequences Source: ERS Live 2007 Year: 2007 Causes and management of exacerbations of COPD Source: ISSN=ISSN 1810-6838, ISBN=, page=250 Year: 2007 Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities Source: Eur Respir J 2014; 43: 662-664 Year: 2014 Impact of halotherapy on COPD exacerbations Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 LSC Abstract – Bacterial burden in rhinovirus-induced asthma exacerbations Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Therapeutic options for COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 Predictors of exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Methodologies for study of COPD exacerbations Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview Year: 2012 The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Management of COPD exacerbations Source: ERS Lung Science Conference 2019 Year: 2019 COPD exacerbations: impact and prevention Source: Breathe 2013; 9: 434-440 Year: 2013 Potential usefulness of phenotyping in asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Phenotype-based therapy of COPD: Effect on the rate of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016